TENAX THERAPEUTICS, INC. Capitalized Costs, Asset Retirement Costs
TENAX THERAPEUTICS, INC. (TENX) had Capitalized Costs, Asset Retirement Costs of $105.00 thousand as of 2015-04-30, per its 10-K filed 2017-03-16.
Discontinued › Notes
us-gaap:CapitalizedCostsAssetRetirementCosts · last filed 2017-03-16
- 2015-04-30: Capitalized Costs, Asset Retirement Costs $105.00K.
- 2014-04-30: Capitalized Costs, Asset Retirement Costs $137.00K.
- 2013-04-30: Capitalized Costs, Asset Retirement Costs $135.00K.
| Period end | Capitalized Costs, Asset Retirement Costs |
|---|---|
| 2015-04-30 | $105.00K 10-K · filed 2017-03-16 |
| 2014-04-30 | $137.00K 10-K · filed 2017-03-16 |
| 2013-04-30 | $135.00K 10-KT · filed 2016-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Lunai Bioworks Inc. (LNAI) | United States | $0.072B | -0.11 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |